| ［1］ |
王瑞棋.非索非那定治疗季节性过敏性鼻炎和慢性特发性荨麻疹的疗效和安全性研究［J］.药物不良反应杂志，2007，9（2）：85-90.
|
| ［2］ |
Mussen F，Salek S，Walker S.A quantitative approach to benefit-risk assessment of medicines—part 1：the development of a new model using multi-criteria decision analysis；part 2：the practical application of a new model［J］.Pharmacoepidemiol Drug Saf，2007，（Suppl 1）：S42-S46.
|
| ［3］ |
邹游，陈始明，张雷波，等.非索非那定治疗变应性鼻炎的随机对照试验的Meta分析［J］.现代生物医学进展，2014，14（24）：4672-4677.
|
| ［4］ |
王玲玲.非索非那定治疗变应性鼻炎有效性及安全性的Meta分析［D］.乌鲁木齐：新疆医科大学，2013.
|
| ［5］ |
Mussen F，Salek S，Walker S，et al.A quantitative approach to benefit-risk assessment of medicines—part 2：the practical application of a new model［J］.Pharmacoepidemiol Drug Saf，2007，（Suppl 1）：S16-S41.
|
| ［6］ |
周殿友.优化后多准则决策分析模型用于药品效益风险评价的研究［D］.太原：山西医科大学，2012.
|
| ［7］ |
De Vos C.Non-interventional study comparing treatment satisfaction in patients treated with antihistamines［J］.Clin Drug Investig，2008，28（4）：221-230.
|
| ［8］ |
Miyabe S，Koizuka I，Ochi K，et al.Effect of fexofenadine hydrochloride on cedar pollinosis［J］.Auris Nasus Larynx，（Suppl）：S61-S68.
|
| ［9］ |
Scha per C，Gustavus B，Koch B，et al.Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis［J］.J Investig Allergol Clin Immunol，2009，19（6）：459-464.
|
| ［10］ |
Bunnag C，Jareoncharsri P，Tunsuriyawong P，et al.A noncomparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis［J］.Asian Pac J Allergy Immunol，2000，18（3）：127-133.
|
| ［11］ |
Horak F，Zieglmayer P，Zieglmayer R，et al.The effects of bilastine compared with cetirizine，fexofenadine，and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber［J］.Inflamm Res，2010，59（5）：391-398.
|
| ［12］ |
Wilson AM，Haggart K，Sims EJ，et al.Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis［J］. Clin Exp Allergy，2002，32（10）：1504-1509.
|
| ［13］ |
Horak F，Stübner P，Zieglmayer R，et al.Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d.and fexofenadine 120 mg o.d.in reducing symptoms of seasonal allergic rhinitis［J］.Int Arch Allergy Immunol，2001，125（1）：73-79.
|
| ［14］ |
Prenner BM，Capano D，Harris AG.Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis：a double-blind comparison with crossover treatment of nonresponders［J］.Clin Ther，2000，22 （6）：760-769.
|
| ［15］ |
Kaiser HB，Gopalan G，Chung W.Loratadine provides early symptom control in seasonal allergic rhinitis［J］.Allergy Asthma Proc，2008，29（6）：654-658.
|
| ［16］ |
Howarth PH，Stern MA，Roi L，et al.Double-blind，placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride（120 and 180 mg once daily）and cetirizine in seasonal allergic rhinitis［J］.Allergy Clin Immunol，1999，104（5）：927-933.
|
| ［17］ |
Chen J，Lin ZP，Ge RM，et al.Treatment of allergic rhinitis with fexofenadine hydrochloride：a multicenter clinical trial ［J］.Pharm Care Res，2006，6（6）：433-435.
|
| ［18］ |
Bernstein DI，Schoenwetter WF，Nathan RA，et al.Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis［J］.Ann Allergy Asthma Immunol，1997，79（5）：443-448.
|
| ［19］ |
De Bruin ML，van Puijenbroek EP，Egberts AC，et al.Nonsedating antihistamine drugs and cardiac arrhythmias-biased risk estimates from spontaneous reporting systems？［J］. Br J Clin Pharmacol，2002，53（4）：370-374.
|
